Literature DB >> 25952352

OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for primary prevention of osteoarthritis by joint injury prevention in sport and recreation.

C A Emery1, E M Roos2, E Verhagen3, C F Finch4, K L Bennell5, B Story6, K Spindler7, J Kemp8, L S Lohmander9.   

Abstract

The risk of post-traumatic osteoarthritis (PTOA) substantially increases following joint injury. Research efforts should focus on investigating the efficacy of preventative strategies in high quality randomized controlled trials (RCT). The objective of these OARSI RCT recommendations is to inform the design, conduct and analytical approaches to RCTs evaluating the preventative effect of joint injury prevention strategies. Recommendations regarding the design, conduct, and reporting of RCTs evaluating injury prevention interventions were established based on the consensus of nine researchers internationally with expertise in epidemiology, injury prevention and/or osteoarthritis (OA). Input and resultant consensus was established through teleconference, face to face and email correspondence over a 1 year period. Recommendations for injury prevention RCTs include context specific considerations regarding the research question, research design, study participants, randomization, baseline characteristics, intervention, outcome measurement, analysis, implementation, cost evaluation, reporting and future considerations including the impact on development of PTOA. Methodological recommendations for injury prevention RCTs are critical to informing evidence-based practice and policy decisions in health care, public health and the community. Recommendations regarding the interpretation and conduct of injury prevention RCTs will inform the highest level of evidence in the field. These recommendations will facilitate between study comparisons to inform best practice in injury prevention that will have the greatest public health impact.
Copyright © 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Injury prevention; Osteoarthritis; Randomized controlled trial; Recommendations

Mesh:

Year:  2015        PMID: 25952352     DOI: 10.1016/j.joca.2015.03.009

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  10 in total

1.  The Role of Athletic Trainers in Preventing and Managing Posttraumatic Osteoarthritis in Physically Active Populations: a Consensus Statement of the Athletic Trainers' Osteoarthritis Consortium.

Authors:  Riann M Palmieri-Smith; Kenneth L Cameron; Lindsey J DiStefano; Jeffrey B Driban; Brian Pietrosimone; Abbey C Thomas; Timothy W Tourville; Athletic Trainers' Osteoarthritis Consortium
Journal:  J Athl Train       Date:  2017-06-02       Impact factor: 2.860

2.  Anti-osteoarthritic effects of ChondroT in a rat model of collagenase-induced osteoarthritis.

Authors:  Jiwon Jeong; Kiljoon Bae; Sun-Gil Kim; Dongwook Kwak; Young-Joo Moon; Chan-Hun Choi; Young-Ran Kim; Chang-Su Na; Seon-Jong Kim
Journal:  BMC Complement Altern Med       Date:  2018-04-19       Impact factor: 3.659

Review 3.  Intervention Strategies Used in Sport Injury Prevention Studies: A Systematic Review Identifying Studies Applying the Haddon Matrix.

Authors:  Ingrid Vriend; Vincent Gouttebarge; Caroline F Finch; Willem van Mechelen; Evert A L M Verhagen
Journal:  Sports Med       Date:  2017-10       Impact factor: 11.136

4.  Towards prevention of post-traumatic osteoarthritis: report from an international expert working group on considerations for the design and conduct of interventional studies following acute knee injury.

Authors:  F E Watt; N Corp; S R Kingsbury; R Frobell; M Englund; D T Felson; M Levesque; S Majumdar; C Wilson; D J Beard; L S Lohmander; V B Kraus; F Roemer; P G Conaghan; D J Mason
Journal:  Osteoarthritis Cartilage       Date:  2018-08-18       Impact factor: 7.507

5.  Ipriflavone attenuates the degeneration of cartilage by blocking the Indian hedgehog pathway.

Authors:  Li Guo; Xiaochun Wei; Zhiwei Zhang; Xiaojian Wang; Chunli Wang; Pengcui Li; Chunfang Wang; Lei Wei
Journal:  Arthritis Res Ther       Date:  2019-05-02       Impact factor: 5.156

Review 6.  Elevation of Pro-Inflammatory Cytokine Levels Following Intra-Articular Fractures-A Systematic Review.

Authors:  That Minh Pham; Julie Ladeby Erichsen; Justyna Magdalena Kowal; Søren Overgaard; Hagen Schmal
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

Review 7.  State of art in intra-articular hip injections of different medications for osteoarthritis: a systematic review.

Authors:  Paola Emilia Ferrara; Sefora Codazza; Daniele Coraci; Giuseppe Malerba; Giorgio Ferriero; Gianpaolo Ronconi
Journal:  BMC Musculoskelet Disord       Date:  2021-11-29       Impact factor: 2.362

8.  Intra-Articular Injection of Cross-Linked Hyaluronic Acid-Dexamethasone Hydrogel Attenuates Osteoarthritis: An Experimental Study in a Rat Model of Osteoarthritis.

Authors:  Zhiwei Zhang; Xiaochun Wei; Jizong Gao; Yu Zhao; Yamin Zhao; Li Guo; Chongwei Chen; Zhiqing Duan; Pengcui Li; Lei Wei
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

9.  A multicenter randomised, 1-year comparative effectiveness, parallel-group trial protocol of a physical therapy approach compared to corticosteroid injection on pain and function related to knee osteoarthritis (PTA Trial)

Authors:  Gail D Deyle; Norman W Gill; Daniel I Rhon; Chris S Allen; Stephen C Allison; Ben R Hando; Evan J Petersen; Douglas I Dusenberry; Nicholas Bellamy
Journal:  BMJ Open       Date:  2016-03-31       Impact factor: 2.692

10.  Comparison of Regenerative Tissue Quality following Matrix-Associated Cell Implantation Using Amplified Chondrocytes Compared to Synovium-Derived Stem Cells in a Rabbit Model for Cartilage Lesions.

Authors:  Hagen Schmal; Justyna M Kowal; Moustapha Kassem; Michael Seidenstuecker; Anke Bernstein; Katharina Böttiger; Tanshiyue Xiong; Norbert P Südkamp; Eva J Kubosch
Journal:  Stem Cells Int       Date:  2018-04-19       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.